Zonisamide improves DLB parkinsonism: A randomized double-blind placebo-controlled phase 3 study

被引：0
|
作者：
Murata, M. [1 ]
Odawara, T. [2 ]
Hasegawa, K. [3 ]
Kajiwara, R. [4 ]
Takeuchi, H. [5 ]
Tagawa, M. [6 ]
Kosaka, K. [7 ]
机构：
[1] Natl Ctr Hosp, Natl Ctr Neurol & Psychiat, Neurol, Tokyo, Japan
[2] Yokohama City Univ, Hlth Management Ctr, Yokohama, Kanagawa, Japan
[3] Sagamihara Natl Hosp, Neurol, Sagamihara, Kanagawa, Japan
[4] Sumitomo Dainippon Pharma Co Ltd, Clin Res, Tokyo, Japan
[5] Sumitomo Dainippon Pharma Co Ltd, Data Sci, Tokyo, Japan
[6] Sumitomo Dainippon Pharma Co Ltd, Med Affairs, Tokyo, Japan
[7] Clin Ian Ctr Minami, Psychiat, Yokohama, Kanagawa, Japan
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2017年 / 381卷
关键词：
D O I：
10.1016/j.jns.2017.08.531
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
504
引用
收藏
页码：185 / 186
页数：2
相关论文
共 50 条
  • [1] Zonisamide improves Parkinsonism in patients with DLB: A double-blind randomized placebo-controlled study
    Murata, M.
    Odawara, T.
    Hasegawa, K.
    Tamai, Y.
    Nakamura, M.
    Shimazu, R.
    Kosaka, K.
    [J]. MOVEMENT DISORDERS, 2015, 30 : S427 - S427
  • [2] ZONISAMIDE IMPROVES PARKINSONISM IN DEMENTIA WITH LEWY BODIES (DLB): A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 3 STUDY
    Hasegawa, K.
    Murata, M.
    Odawara, T.
    Kajiwara, R.
    Takeuchi, H.
    Maruyama, H.
    Kosaka, K.
    [J]. PARKINSONISM & RELATED DISORDERS, 2018, 46 : E26 - E26
  • [3] Zonisamide Improves Parkinsonism Without Psychiatric Deterioration in Patients with DLB: A Double-Blind Randomized Placebo-Controlled Study
    Odawara, Toshinari
    Murata, Miho
    Hasegawa, Kazuko
    Tamai, Yoichi
    Nakamura, Masatoshi
    Kosaka, Kenji
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2016, 24 (03): : S160 - S161
  • [4] Adjunct zonisamide to levodopa for DLB parkinsonism: A randomized double-blind phase 2 study
    Murata, Miho
    Odawara, Toshinari
    Hasegawa, Kazuko
    Iiyama, Sayaka
    Nakamura, Masatoshi
    Tagawa, Masaaki
    Kosaka, Kenji
    [J]. NEUROLOGY, 2018, 90 (08) : E664 - E672
  • [5] Zonisamide improves parkinsonism in DLB patients: A randomized phase 3 trial
    Murata, M.
    Odawara, T.
    Hasegawa, K.
    Kajiwara, R.
    Takeuchi, H.
    Tagawa, M.
    Kosaka, K.
    [J]. MOVEMENT DISORDERS, 2018, 33 : S8 - S9
  • [6] Zonisamide in the treatment of painful diabetic neuropathy: A randomized, double-blind, placebo-controlled pilot study
    Atli, A
    Dogra, S
    [J]. PAIN MEDICINE, 2005, 6 (03) : 225 - 234
  • [7] Acupuncture improves sleep in postmenopause in a randomized, double-blind, placebo-controlled study
    Hachul, H.
    Garcia, T. K. P.
    Maciel, A. L.
    Yagihara, F.
    Tufik, S.
    Bittencourt, L.
    [J]. CLIMACTERIC, 2013, 16 (01) : 36 - 40
  • [8] Melatonin improves sleep in asthma - A randomized, double-blind, placebo-controlled study
    Campos, FL
    da Silva, FP
    de Bruin, VMS
    de Bruin, PFC
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (09) : 947 - 951
  • [9] GLANCE Results of a phase 2, randomized, double-blind, placebo-controlled study
    Goodman, A. D.
    Rossman, H.
    Bar-Or, A.
    Miller, A.
    Miller, D. H.
    Schmierer, K.
    Lublin, F.
    Khan, O.
    Bormann, N. M.
    Yang, M.
    Panzara, M. A.
    Sandrock, A. W.
    [J]. NEUROLOGY, 2009, 72 (09) : 806 - 812
  • [10] REGENERATE: A Global Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of OCA for NASH
    Ratziu, Vlad
    Sanyal, Arun J.
    MacConell, Leigh
    Herrmann, Sibylle
    Shringarpure, Reshma
    Marmon, Tonya
    Shapiro, David
    Younossi, Zobair M.
    [J]. SWISS MEDICAL WEEKLY, 2016, 146 : 17S - 17S
12345